NEW QUALIFIED HEALTH CLAIM for magnesium and reduced risk of high blood pressure

Jan 13, 2022

Dear Colleagues —

I am pleased to inform you that on January 10 the FDA issued the attached constituent update advising the Center for Magnesium Education and Research that FDA is authorizing three qualified health claims regarding the relationship between consumption of magnesium and the reduced risk of high blood pressure.

As you will see in the constituent letter, FDA is allowing three separate qualified health claims that may be used on labels and labeling, provided the text of each claim is used just as FDA has stated.

We congratulate Mr. Johnson and the Center for Magnesium Education and Research for their efforts to have these qualified health claims recognized by FDA. On a personal note, I take magnesium daily as many others do and now hope that the great benefits of magnesium will come to broader public attention.

Finally, FDA’s response letter is 42 pages long and provides an exhaustive review of the literature and the rationale for establishing the claims as they did. This is a very useful document. We encourage you to review it, should you now choose to use one or all of these qualified health claims.

Cordially,

LDI

News

UNPA Interview | ANS & Alkemist Labs introduce the Testing Transparency Program

Mar 16, 2023

Arizona Nutritional Supplements (ANS), celebrating over 25 years as a full-service dietary supplement contract manufacturer, has joined the Alkemist Labs Alkemist Assured™ testing

UNPA Interview | Interested in the quality of your supplement? ConsumerLab.com is too.

Mar 2, 2023

Lisa Sabin of ConsumerLab.com provides the latest news and insights on dietary supplement testing and product quality as well as their annual consumers’

Khan recognized for contributions to safety, effectiveness of botanical dietary supplements

Feb 3, 2023

Ikhlas Khan, internationally recognized for his research on the chemistry and biological activity of medicinal plants and supplements, has been elected as a